SCHEMBL565338

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL472683	0.88	CA1 (0.34)	SMN1; SMN2MAPTHTTGAAKDM4E
	SCHEMBL472766	0.88	CA1 (0.32)	—
	SCHEMBL472706	0.88	CA1 (0.32)	—
	SCHEMBL566693	0.87	GAA (0.36)	ORAI1SMN1; SMN2MAPTGAAKDM4E
	SCHEMBL472626	0.87	CA1 (0.32)	—
	SCHEMBL13258864	0.87	CA1 (0.32)	—
	SCHEMBL10132745	0.86	HTT (0.35)	SMN1; SMN2TP53MAPTHTTGAA
	SCHEMBL472694	0.86	NPSR1 (0.33)	CYP2C19MAPTHTTGAALMNA
	SCHEMBL472543	0.85	CA1 (0.31)	—
	SCHEMBL472682	0.85	CA1 (0.32)	GAAKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.